Literature DB >> 2861616

Beta-carbolines can enhance or antagonize the effects of punishment in mice.

D N Stephens, W Kehr.   

Abstract

Six beta-carboline ligands at central benzodiazepine (BZ) receptors were tested for their anxiolytic or anxiogenic properties in mice in the four-plate test. ZK 93 423 and ZK 91 296 increased activity which had been suppressed by punishment (1 mA, 60 ms footshock) at doses which exerted no effect on unpunished locomotion. ZK 93 426, ZK 90 886, FG 7142, and DMCM exerted no antipunishment activity themselves, and antagonized the ability of diazepam to increase both punished and unpunished locomotor activity. DMCM, FG 7142, and ZK 90 886, but not ZK 93 426, also enhanced the ability of a reduced level of footshock (0.3 mA) to suppress activity. This propunishment activity of DMCM and ZK 90 886 took place at doses which had no effect on unpunished locomotion. The nature of the effect of the individual beta-carbolines on punishment was related to the nature of their interaction with the BZ/GABA receptor/chloride channel complex (GBC complex). Thus the antipunishment properties of ZK 93 423 and ZK 91 296 were associated with their ability to increase binding of 35S-t-butylbicyclo-phosphorothionate (TBPS) to its binding site associated with the chloride channel, whereas DMCM, FG 7142 and ZK 90 886, which exerted propunishment effects, reduced TBPS binding. ZK 93 426, which was neutral with respect to punished activity, had the weakest effect on TBPS binding. These results are discussed in the context of a possible role of GBC complex in anxiety.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2861616     DOI: 10.1007/bf00428403

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  A new method for rapid screening of minor tranquillizers in mice.

Authors:  J R Boissier; P Simon; C Aron
Journal:  Eur J Pharmacol       Date:  1968-09       Impact factor: 4.432

2.  gamma-Aminobutyric acid regulation of the benzodiazepine receptor: biochemical evidence for pharmacologically different effects of benzodiazepines and propyl beta-carboline-3-carboxylate.

Authors:  F J Ehlert; W R Roeske; C Braestrup; S H Yamamura; H I Yamamura
Journal:  Eur J Pharmacol       Date:  1981-04-09       Impact factor: 4.432

3.  The anxiogenic action of FG 7142 in the social interaction test is reversed by chlordiazepoxide and Ro 15-1788 but not by CGS 8216.

Authors:  S E File; S Pellow
Journal:  Arch Int Pharmacodyn Ther       Date:  1984-10

4.  Ligands for benzodiazepine receptors with positive and negative efficacy.

Authors:  C Braestrup; T Honoré; M Nielsen; E N Petersen; L H Jensen
Journal:  Biochem Pharmacol       Date:  1984-03-15       Impact factor: 5.858

5.  Facilitation of benzodiazepine binding by sodium chloride and GABA.

Authors:  I L Martin; J M Candy
Journal:  Neuropharmacology       Date:  1978-11       Impact factor: 5.250

6.  Potentiation by intraventricular muscimol of the anticonflict effect of benzodiazepines.

Authors:  A R Cananzi; E Costa; A Guidotti
Journal:  Brain Res       Date:  1980-09-08       Impact factor: 3.252

7.  Benzodiazepine receptor-mediated experimental "anxiety" in primates.

Authors:  P T Ninan; T M Insel; R M Cohen; J M Cook; P Skolnick; S M Paul
Journal:  Science       Date:  1982-12-24       Impact factor: 47.728

Review 8.  Behavioral analogues of anxiety. Animal models.

Authors:  H Lal; M W Emmett-Oglesby
Journal:  Neuropharmacology       Date:  1983-12       Impact factor: 5.250

9.  A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, beta-carbolines, and phenobarbitone.

Authors:  P Polc; E P Bonetti; R Schaffner; W Haefely
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  15 in total

1.  Human studies on the benzodiazepine receptor antagonist beta-carboline ZK 93,426: preliminary observations on psychotropic activity.

Authors:  T Duka; D N Stephens; W Krause; R Dorow
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Safety signal withdrawal: a behavioural paradigm sensitive to both "anxiolytic" and "anxiogenic" drugs under identical experimental conditions.

Authors:  M H Thiébot; L Dangoumau; G Richard; A J Puech
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  The effect of the beta-carboline FG 7142 on the behaviour of male rats in a living cage: an ethological analysis of social and nonsocial behaviour.

Authors:  C H Beck; S J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Effect on hypothalamic self-stimulation of the novel beta-carbolines ZK 93 426 (a benzodiazepine receptor antagonist) and ZK 91 296 (a putative partial agonist).

Authors:  L J Herberg; A M Montgomery; S E File; S Pellow; D N Stephens
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 5.  Anxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls.

Authors:  M H Thiébot; P Soubrié; D Sanger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity?

Authors:  D N Stephens; B S Meldrum; R Weidmann; C Schneider; M Grützner
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Proconflict and electrocorticographic effects of drugs modulating GABAergic neurotransmission.

Authors:  J M Stutzmann; G A Böhme; M Cochon; M Roux; J C Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Effects of benzodiazepine receptor ligands on the performance of an operant delayed matching to position task in rats: opposite effects of FG 7142 and lorazepam.

Authors:  B J Cole; M Hillmann
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

9.  ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma.

Authors:  L Turski; A Huth; M Sheardown; F McDonald; R Neuhaus; H H Schneider; U Dirnagl; F Wiegand; P Jacobsen; E Ottow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Human studies on abecarnil a new beta-carboline anxiolytic: safety, tolerability and preliminary pharmacological profile.

Authors:  T Duka; B Schütt; W Krause; R Dorow; S McDonald; K Fichte
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.